GLP-1 Drugs May Manage Weight Recurrence After Bariatric Surgery

Glucagon-like peptide-1 (GLP-1) receptor agonists may support weight management in patients following bariatric surgery. A study suggests that GLP-1 drug use is particularly common among those with less postsurgical weight loss.

Authors

Publication Details

Journal
JAMA
Published
2025-09-19
DOI
https://doi.org/10.1001/jama.2025.13880
Primary Topic
Bariatric Surgery and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GLP-1 Drugs May Manage Weight Recurrence After Bariatric Surgery

Samantha Anderer
JAMA
Bariatric Surgery and Outcomes
article

GLP-1 Drugs May Manage Weight Recurrence After Bariatric Surgery

Samantha Anderer
article en

Abstract

Glucagon-like peptide-1 (GLP-1) receptor agonists may support weight management in patients following bariatric surgery. A study suggests that GLP-1 drug use is particularly common among those with less postsurgical weight loss.

JAMAVol. 334(15)
Openalex Percentile: Top 59%
Bariatric Surgery and Outcomes
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GLP-1 Drugs May Manage Weight Recurrence After Bariatric Surgery — Samantha Anderer · JAMA (2025) | TGRS Research Map | TGRS